A new genomics venture co-founded by Abasi Ene-Obong after leaving 54gene.
This Nigerian startup wants your DNA to rewrite global medicine
Syndicate Bio launched in September 2023 to enhance genomics and precision medicine in Africa. The company aims to address the lack of African genomic data, which hampers disease prevention and treatment.
Nigerian court stops 54gene asset sale as founder accuses investors of collapse
A Federal High Court in Lagos has stopped the sale of 54gene’s assets. Founder Abasi Ene-Obong filed a lawsuit against investors alleging forced collapse.
54gene founder breaks silence on resignation, opens up about personal struggles
Dr. Abasi Ene-Obong's LinkedIn post clarifies circumstances of his departure from 54gene. He described his resignation as part of a 'hostile takeover' attempt.
Nigerian startup Syndicate Bio partners NICRAT to launch cancer genome project
Strategic partnership between Syndicate Bio and NICRAT to launch the Cancer Genome Nigeria project. Study aims to bridge cancer disparity gaps and study prevalent cancers across Nigeria.
